AM2022 Antitrust Law Section (Day Two)

Topics to be Included:

• Developments in Pharma Antitrust: Evolution or Revolution?
• Zero-Price Markets and the Boundaries of Antitrust Law
• Should The Antitrust Laws Be Used to Promote Societal Change? An Exploration of The Intersection Between Antitrust Enforcement and the Promotion of Environmental and Social Welfare

Speakers

M. Elaine Johnston, Esq., Allen & Overy LLP, New York, NY

Dr. Christine Siegwarth Meyer, Managing Director and Chair of Intellectual Property Practice, NERA Economic Consulting, New York, NY

Robin Adelstein, Esq., Norton Rose Fulbright US LLP, New York, NY and Washington, D.C.

Michael Kades, Esq., Director of Markets and Competition Policy, Washington Center for Equitable Growth, Washington, D.C.

Andreas Mundt, President, Bundeskartellamt, Bonn, Germany

Makan Delrahim, Esq., Former Assistant Attorney General for the Antitrust Division, U.S. Department of Justice, Washington, D.C.

Dr. Cristina Caffarra, Senior Consultant, Charles River Associates, London, United Kingdom